Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.69 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.69 |
| ▸ | ANPEP | P15144 | 1/20 | 0.67 |
| ▸ | DPP4 | P27487 | 2/20 | 0.64 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.59 |
| ▸ | TGM2 | P21980 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3703 | 1.00 | DPP8 (0.69) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL10962932 | 1.00 | DPP8 (0.69) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL20570522 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL20570366 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Hydrochloric Acid SCHEMBL9317271 | 0.99 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL9656664 | 0.96 | DPP8 (0.64) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL31134030 | 0.93 | DPP8 (0.68) | DPP8DPP7ANPEPDPP4DPP9 | |
| Phenylalanine SCHEMBL10348899 | 0.93 | DPP8 (0.62) | DPP8DPP7ANPEPDPP4DPP9 | |
| Trifluoroacetic Acid SCHEMBL30788185 | 0.93 | DPP8 (0.62) | DPP8DPP7ANPEPDPP4DPP9 | |
| SCHEMBL23542526 | 0.92 | DPP8 (0.64) | DPP8DPP7ANPEPDPP4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126117-A | Synthesis method of copper peptide | 深圳市维琪科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-114891063-B | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-114891063-A | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-118126117-A | Synthesis method of copper peptide | 深圳市维琪科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118126117-A | Synthesis method of copper peptide | 深圳市维琪科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-113461774-B | Preparation method of palmitoyl tripeptide-1 | 深圳瑞德林生物技术有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116874486-A | Amino acid modified S, S-heptacyclic carboxylic acid chemical synthesis, antithrombotic activity and application | 首都医科大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116284218-A | Method for synthesizing palmitoyl tripeptide-1 based on liquid phase carrier assistance | 常州大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-114891063-B | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-114891063-A | Liquid phase synthesis method of palmitoyl tripeptide-1 | 浙江湃肽生物股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| EP-1210335-B1 | AMINOCARBONYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR PRODUCING SAME AND THE USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-09-14 | — | — | EP | disclosed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | disclosed |
| US-6512000-B1 | Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-01-28 | — | — | US | disclosed |
| EP-1210335-A1 | AMINOCARBONYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR PRODUCING SAME AND THE USE THEREOF AS MEDICAMENTS | Boehringer Ingelheim Pharma KG (DE) | 2002-06-05 | — | — | EP | disclosed |
| WO-2001014342-A1 | AMINOCARBONYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR PRODUCING SAME AND THE USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-03-01 | — | — | WO | disclosed |
| US-5399578-A | Hypotensive; valsartan; high blood pressure and cardiac insufficiency | CIBA-GEIGY CORP (US) | 1995-03-21 | — | — | US | disclosed |